FDA to Implement Major Reorganization, Ending Specialized Inspections
The Food and Drug Administration (FDA) is set to implement a significant reorganization starting October, consolidating administrative functions across its nine centers and ending the specialization of its field inspectors. This move, approved during the Trump administration, aims to streamline operations under a 'shared service' model. Inspectors will now operate as generalists, conducting inspections across various industries rather than focusing on specific areas. The reorganization is part of the 'Simple Reform' initiative, which seeks to enhance efficiency and consistency within the agency. 
